Women’s Health And FemTech
Conference
Harnessing technology, innovation and investment to bridge the gender health divide
Delegate guide
In partnership with
Executive & Drinks Partner
Exhibitors
1 | Women’s Health and FemTech Conference
Executive Partner
Media Partner
laingbuissonevents.com
2 | Women’s Health and FemTech Conference
laingbuissonevents.com
Contents Agenda
6
Speakers
9
Partners & Exhibitors
18
Delegates
22 This is an interactive delegate guide.
All adverts are clickable and will redirect you to the linked page. Company logos and social media links are also interactive.
Click on a heading in the table of contents to jump to the page.
Questions & polls
Delegates are invited to post their questions using the online platform sli.do. Join in the debate. Today is not all talk. It’s about shaping the debate and calls to action. Tell us what you think needs to change to improve outcomes for women’s health via the qr code. WiFi network name:
Union Street Guest
Password:
10#UnionSt
Event code:
#WHC26
If you would like to ask a question in person, delegates are asked to wait for the roving microphone and to state their name and organisation During the panel sessions the panellists will be asked to offer their views before the debate is opened up to the floor 1
2
Open browser
Go to slido.com
3
Enter event code
Women’s Health and FemTech Conference | 3
4 | Women’s Health and FemTech Conference
laingbuissonevents.com
Women’s Health and FemTech Conference | 5
Agenda 08:15
09:00
Registration & Welcome Refreshments Introduction from the Conference Director and Conference Partner Mills & Reeve Maria Davies, Head of Content, LaingBuisson Jill Mason, Partner and Head of Health and Care, Mills & Reeve
Opening keynote: The state we’re in 09:10
Charlotte Lewis, Principal Associate. Commercial Health and Health Tech Lawyer, Mills & Reeve Kate Lancaster, Chief Executive Officer, Royal College of Obstetricians and Gynaecologists Professor Dame Lesley Regan DBE, Women’s Health Ambassador for England, Department of Health and Social Care
Shadow Banning and Online Censorship Sophie Burton-Jones, Partner, Mills & Reeve
9:50
Anna O’Sullivan, Co-Founder, CensHERship Paulina Szklarek, Managing Director, Mooncup Nina van Schaick, Co-Founder, Peripear
10:35
10:50
The shape we’re in: How are independent healthcare providers delivering services for women? Danielle Henry, Director of Policy, Independent Healthcare Providers Network (IHPN)
The shape we’re in: How are women accessing private healthcare? Nathalie Alpi, Digital and Analytics Operations Director, Private Healthcare Information Network (PHIN)
Q&A with keynote speakers 11:05
Edward Ungar, Co-Founder & CEO, Pharmacierge Danielle Henry, Director of Policy, IHPN Nathalie Alpi, Digital and Analytics Operations Director, PHIN
11:20
Networking break and exhibitor showcase Data & clinical trials panel: Turning evidence into better care Isabel Teare, Senior Legal Advisor, Mills & Reeve
11:50
Janet Lindsay, CEO, Wellbeing of Women Sarita Stefani, Co-Founder & CEO, Amilis Tina Backhouse, Co-Chair, Menopause Mandate
6 | Women’s Health and FemTech Conference
laingbuissonevents.com
Building a clinic panel: Creating sustainable women’s health services Gayle Curry, Partner and Healthcare and Health Tech Commercial Lawyer, Mills & Reeve
12:40
Daniel Bulkin, Founder and CEO, Healistic Nicola Aspinall, Chief Executive, London Gynaecology Dr Susheel K Randhawa, Clinical Lead, Community Gynaecology Modality LLP Suzanne Dickinson, Director Business Development & Engagement, MSI UK
13:25
Lunch and networking break FemTech & virtual clinic panel: Technology’s role in helping bridge the gap Dr Sara Khan, Women’s Health & FemTech Advisor, Candesic
14:25
Kayleigh Hartigan, Founder &CEO, SEEN Lily Elsner, CEO & Co-Founder, Jack Fertility Mary O’Reilly, Founder, MOR Advisory & Investor & Strategic Advisor, 28X Dr Sujitha Selvarajah, Obstetrics and Gynaecology Doctor; Co-Founder, Hesta Health
15:15
Looking after the female workforce: Do corporates really care? Dr Jane Benjamin, Women’s Health Lead, HCA Primary Care
Funding and finance panel: Funding the future of women’s health Thilo Schneider, Head of Corporate, Mills & Reeve
15:35
Lara Tentori, Associate Director - Healthcare & Life Science M&A, Alvarez & Marsal Sharon Shier, Executive Director and Chief Customer Officer, WPA Victoria Wain, Investment Director, Phoenix Equity Partners Wendy Powell, Founder, MUTU System
16:20
16:45
Afternoon break and networking The Vagina Business: The Innovative Breakthroughs that Could Change Everything in Women’s Health: In conversation with award-winning author Marina Gerner Charlotte Lewis, Principal Associate. Commercial Health and Health Tech Lawyer, Mills & Reeve Marina Gerner, Author of The Vagina Business
17:10
Conference closing remarks, calls to action and Drinks Reception speech by Pharmacierge
Women’s Health and FemTech Conference | 7
8 | Women’s Health and FemTech Conference
laingbuissonevents.com
Speakers Anna O’Sullivan - Co-Founder, CensHERship
Anna O’Sullivan is the co-founder of CensHERship, a research and advocacy initiative tackling the barriers women’s health organisations, professionals and educators face across digital platforms and financial services. CensHERship investigates issues including content moderation, advertising restrictions and access to financial services, and works with industry and policymakers to drive systemic change. Its work includes FemTick, a global accreditation standard designed to recognise platforms and financial providers that support women’s health fairly and consistently. Anna is also the founder of FutureFemHealth, a global media and market intelligence platform covering the business and innovation shaping women’s health, reaching more than 100,000 readers each month. She has two decades of experience across corporate communications, PR and journalism, including as a director at a FTSE 100 company.
Charlotte Lewis - Principal Associate. Commercial Health and Health Tech Lawyer, Mills & Reeve
Charlotte Lewis is a commercial health lawyer with specialist interest in healthcare, health technology and women’s health. She leads our Women’s Health team.
She advises organisations on legal, commercial and strategic issues relating to commissioning, contracting and collaborating and is very familiar with complex healthcare contracts. She has worked on a range of health and social care projects from system and place-based integration and provider collaboration to electronic patient record procurements and digital health platform development. Charlotte is co-vice chair of Tech UK’s Health and Social Care Council.
Daniel Bulkin - Founder & CEO, Healistic
Daniel Bulkin is the founder and CEO of Healistic, a UK-based healthtech platform digitally connecting clinics, pharmacies and patients. Healistic enables clinicians to prescribe medications in a matter of seconds, with prescriptions seamlessly fulfilled through Healistic’s nationwide network of trusted pharmacy partners. Medications are delivered directly to patients’ homes within hours Daniel previously founded a series of other businesses and runs an investment syndicate, backing early-stage businesses across Europe. Before becoming an operator, he was an Investment Manager at Private Equity firm H.I.G. Capital, executing on healthcare and technology investments. His board involvements included HCS Group, McDonalds Nordics and Welcome Hotels.
Danielle Henry - Director of Policy, IHPN
Danielle Henry was appointed IHPN’s Director of Policy in February 2025, having previously been Assistant Director of Policy & Programmes, leading on diagnostics, primary and community healthcare policy, as well as work to support members in achieving Net Zero. Prior to joining IHPN, Danielle worked in local government policy for 10 years, and began her career in project delivery in the private sector.
Edward Ungar - CEO & Co-Founder, Pharmacierge
Edward Ungar is Co-founder and CEO of Pharmacierge, a leading healthtech creating ePrescribing apps for private prescription delivery. After Google EMEA Director, he became CCO at Onfido, and held prior roles at the FT and Goldman Sachs. He studied languages at Cambridge and holds an MBA from IE in Madrid.
Women’s Health and FemTech Conference | 9
Speakers Gayle Curry - Partner. Healthcare and Health Tech Commercial Lawyer, Mills & Reeve Gayle Curry is a commercial partner with a specialist interest in healthcare and health tech solutions that improve health and social care outcomes. She leads our Health Tech practice She has over 25 years' experience of finding commercial legal solutions for businesses, helping them achieve their growth plans through protection and exploitation of intellectual property rights, grant funding agreements, trading terms and conditions and innovative collaborations with customers and suppliers including universities and the NHS.
She is often called upon by clients to help them shape their strategies and sometimes to act as their fractional general counsel. Clients are wide ranging in size from SMEs to large international businesses and NHS organisations. She has experience of working on projects involving diagnostics, precision medicine, prevention, robotics, genomics, long term conditions monitoring and treatment, women’s health solutions and patient communications systems. Gayle regularly speaks at conferences and works on the firm’s India desk, having visited Mumbai to meet our Indian clients and contacts. She particularly enjoys advising at the interface of health policy and the law. She has held a non-executive directorship in the NHS acute sector.
Isabel Teare - Senior Legal Advisor, Mills & Reeve
Isabel Teare is a senior life sciences lawyer with a specialist interest in life sciences, technology and healthtech. She is part of Mills & Reeve's multidisciplinary life sciences team, supporting clients across the pharmaceuticals, biotech, medical device, diagnostics, medtech/healthtech and digital health sectors.
Her practice spans regulatory compliance, intellectual property and commercial contracting, and she regularly advises on the UK and EU regulatory frameworks governing pharmaceuticals, medical devices, AI-enabled technologies, advertising and promotion, and clinical research. She has advised on compliance and contracting for international and UK-based clinical trial programmes, collaborative projects between healthcare and life sciences organisations, and classification and compliance issues for innovative products such as AI-enabled tools, and has supported multiple biotechnology licensing and product development projects addressing complex inter-related IP, contractual and regulatory considerations. She is known for clear, practical guidance in highly technical, fast-evolving areas of law. Isabel is a member of the firm's women's health team, and regularly writes and speaks on life sciences and healthtech issues.
10 | Women’s Health and FemTech Conference
laingbuissonevents.com
Dr Jane Benjamin - Women's Health Lead, HCA Primary Care
Dr Jane Benjamin is the Women’s Health Lead for HCA Primary Care, Co-Chair of the HCA Menopause Service Group, and a member of the HCA Clinical Innovation Board.
Dr Benjamin qualified in Medicine from the University of Cape Town in 2004 before moving to the UK, where she worked within leading NHS hospitals. In 2011, she completed a Doctorate in Nutrition and Gastroenterology through King’s College London, further developing her expertise in the relationship between nutrition, long-term health and disease prevention. Alongside her clinical practice, which spans General Practice, Occupational Health and Health Screening, Dr Benjamin has developed particular expertise in women’s health, preventative medicine and workplace wellbeing. She is passionate about translating clinical evidence into practical health strategies that support individuals while helping organisations build healthier, more resilient and productive workforces. Through her leadership roles, including her work on the Clinical Innovation Board, Dr Benjamin contributes to the development and evolution of healthcare services, with a focus on improving clinical outcomes, patient experience and the delivery of innovative, evidence-based approaches to healthcare.
Her work encompasses the development of corporate health and wellbeing strategies, with a particular focus on women’s health across the employee lifecycle, health education, early identification of risk, prevention and access to appropriate clinical support. She is a strong advocate for moving beyond reactive healthcare towards a more proactive model that enables organisations to identify health needs early and create environments in which employees can thrive. Dr Benjamin is also actively involved in health promotion and medical education, helping to raise awareness of key health conditions and translating complex medical topics into accessible, evidence-based guidance for both individuals and organisations.
She brings together clinical expertise, strategic health leadership and a strong understanding of the modern workplace, providing an informed perspective on how organisations can embed health, prevention and wellbeing into their broader corporate strategy.
Janet Lindsay – CEO, Wellbeing of Women
Janet Lindsay is CEO of Wellbeing of Women, a leading charity working to save and improve the lives of women, girls and babies and to power research breakthroughs in women’s health. Janet started her career working for a global advertising firm before running her own communications agency. Prior to joining Wellbeing of Women, Janet worked for Great Ormond Street Hospital Children’s Charity and Starlight Children’s Foundation in fundraising and communications roles.
Jill Mason - Partner and Head of Health and Care, Mills & Reeve
Jill is Head of the Health & Care Sector at national law firm Mills & Reeve. She also leads our Healthcare Law and Mental Health Law practice – the team that advise on the law relating to patients and service users, both children and adults.
She has over 30 years’ experience of advising clients in both the public and independent sectors on all manner of healthcare law matters. Her expertise covers a range of areas including Risk Management, Investigations and Inquiries, Quality and Governance, Commissioning and advice on the Mental Capacity Act 2005 and Mental Health Act 1983.
Jill frequently writes and speaks on key issues of the day to our clients and at external events. Jill contributed a chapter on Incidents, Early Resolution, Inquests and Learning to Restorative Just Culture In Practice. Other authors included the former Secretary of State for Health, Jeremy Hunt. Our third Fem Health roundtable, which led to the report entitled “Current Realities and Future Horizons”, was co-chaired by Jill.
Jill launched our Mills & Reeve Women in Health and Care Network in 2023 which has attracted a variety of amazing female speakers including Baroness Helena Morrissey and Dr Louise Newson.
Under her term as Head of our Health & Care Sector the team have won many awards including, most recently, Health Investor Legal Advisors of the Year, Private, in 2025 and Public in 2026. Jill is ranked in the Hall of Fame in Legal 500 and listed as an Eminent Practitioner by Chambers.
Women’s Health and FemTech Conference | 11
Speakers Kate Lancaster - Chief Executive Officer, Royal College of Obstetricians and Gynaecologists
Kate is the Chief Executive of the Royal College of Obstetricians and Gynaecologists (RCOG) based in London, UK. The RCOG is a global organisation dedicated to improving the health of women and girls across the world through the work of its Fellows and Members. Its work spans more than 100 countries, setting professional standards and leading projects to improve women’s health globally, in collaboration with professionals, health authorities and governments. Kate has also invested in building successful international partnerships for the benefit of women’s health world-wide and has led the work to establish the women’s health hub at the RCOG in Union Street, creating a growing collaborative community of 15 women’s health organisations, including the Royal College of Midwives.
Prior to joining the RCOG in 2019, Kate held a number of Board Director roles in both the English and Scottish National Health Service, including roles at Cambridge University Hospitals NHS FT, Royal Papworth NHS FT and NHS Forth Valley. Kate also held senior leadership roles within Cambridge University Health Partners, an academic health science centre, and the Eastern Academic Health Science Network where she built partnerships across the health service, industry and academia. Kate is passionate about improving the health of women and girls and has a keen interest in how technology such as femtech and AI can be used to solve some of the intractable issues within healthcare. In addition to her Chief Executive role, Kate is the Senior NonExecutive Director of the Kent, Surrey and Sussex Academic Health Science Network. Kate mentors a number of senior leaders, is a qualified leadership coach and is an Associate Alumni of the Judge Business School, University of Cambridge.
Kayleigh Hartigan - Founder & CEO, SEEN
Kayleigh Hartigan is the Founder & CEO of SEEN, the execution layer for self-pay healthcare, starting with assisted fertility. Over two decades she has built healthcare systems and scaled health tech across Europe and the US - including as CCO of ZAVA (exited to Hims & Hers) and VP & Chief of Staff at HealthHero, Europe's largest digital health provider. She designed NHS health systems for the CEO, founded Marwood Group's European M&A practice advising large-cap PE on healthcare investments, and began her career in policy at the Department of Health, WHO and DfID. A public voice on funding and access to quality self-pay healthcare, she has featured on Sky News, the BBC and beyond.
Lara Tentori - Associate Director - Healthcare & Life Science M&A, Alvarez & Marsal Lara Tentori is an Associate Director in Alvarez & Marsal's Healthcare & Life Sciences M&A team, where she advises founders, management teams and investors on healthcare transactions across the UK and Europe. With nine years of M&A experience dedicated exclusively to the healthcare sector, she has worked across a broad range of subsectors, including healthcare services, pharma services, medtech and digital health. Lara has a particular passion for women's health, with a strong interest in supporting innovation and improving access to investment for businesses addressing unmet needs across the sector.
12 | Women’s Health and FemTech Conference
laingbuissonevents.com
Professor Dame Lesley Regan DBE - Women’s Health Ambassador for England, Department of Health and Social Care
Dame Lesley Regan is Professor of Obstetrics & Gynaecology, Imperial College at St Mary’s campus, She has chaired Wellbeing of Women since 2020, hosting webinars and debates on many aspects of women’s health across the span of the lifecourse in order to promote funding for the charity’s research, education and advocacy programmes.
Professor Regan is a globally recognised authority in women’s health, having been President of the Royal College of Obstetricians and Gynaecologists from 2016 to 2019 and Honorary Secretary of the International Federation of Gynecology and Obstetrics (FIGO) from 2018-2023. In June 2022, Dame Lesley became the first ever Women’s Health Ambassador for England. Her role involves collaborating with the government, voluntary and charitable sectors to shape and support the implementation of the Women’s Health Strategy. The strategy is an ambitious 10 year plan to improve the health outcomes and wellbeing of all girls and women. The year 1 priorities have focussed on improving access to care, bridging health disparities and confronting the many taboos surrounding common gynaecological problems such as heavy painful periods, fertility, pregnancy loss, menopause, pelvic floor problems and the importance of providing long acting reversible contraception and safe abortion care. She has written best-selling books on pregnancy and miscarriage to provide women with vital information to empower them to recognise when they need to seek help and ensure that their problems are resolved swiftly allowing them to get on with their daily lives.
Lily Elsner - CEO & Co-Founder, Jack Fertility
Lily Elsner is the CEO and Co-Founder of Jack Fertility, an Oxford-based startup revolutionising male reproductive health with the UK's first postal, home-to-lab semen analysis kit, which launched UK-wide in May! On a mission to shift reproductive health from reactive to preventative, Lily is helping to mitigate the fertility burden on women while empowering men and people with sperm in their fertility journeys. A recipient of the Innovate UK Young Innovator Award, she holds an MBA from Oxford and a BA in Biology & Philosophy from Wellesley College. Lily's work on Jack has been featured in GQ, Men's Health, Sifted, and more, putting male fertility, finally, in the spotlight.
Marina Gerner – Author of The Vagina Business
Marina Gerner is the author of The Vagina Business: The Innovative Breakthroughs that Could Change Everything in Women's Health. Focused on world-leading innovation in women’s health from fertility to menopause and beyond the uterus, the book has been chosen a Book of the Month by the Financial Times and won the Porchlight Business Book Award and the Mindvalley Book Club Award. As a journalist, Marina has written for publications including The Times, Wall Street Journal, Money Observer, and Wired, alongside publishing her own newsletter on Substack. And, as an academic she is an Adjunct Professor at NYU’s Stern School of Business (London campus) and holds a PhD from the London School of Economics.
An inspiring speaker on innovation in women’s health, Marina speaks at tech conferences, female empowerment summits, book clubs, universities, clubs, and employee events around the world. Born in Kyiv, she was raised in Frankfurt, briefly lived in New York, and has mainly lived in London, where she can be found drinking cappuccinos with friends and taking her toddler to bars.
Mary O’Reilly – Founder, MOR Advisory; Investor & Strategic Advisor, 28X
Mary O’Reilly is a healthcare leader, investor and strategic adviser with a particular focus on women’s health, prevention and innovation. Through MOR Advisory, she works with founders and healthcare organisations on strategy, growth, investment and reputation. Mary is an investor and strategic adviser to 28X, a free, privacy-first women’s health platform designed to make trusted health information accessible to women and girls globally. She previously spent eight years leading corporate affairs, brand and marketing at Nuffield Health, where she was a member of the Executive Committee.
Women’s Health and FemTech Conference | 13
Speakers Nathalie Alpi - Digital and Analytics Operations Director, PHIN
Nathalie has been working at PHIN for two years and is a strategic, results-driven leader with a proven track record of achieving operational excellence in the tech industry, both agency- and client-side. She is skilled in optimising efficiency and profitability, enhancing team performance, and driving business growth.
Nicola Aspinall - Chief Executive, London Gynaecology
Nicola Aspinall is Chief Executive Officer of London Gynaecology, one of the UK’s leading private women’s health practices, where she is leading the organisation through its next phase of growth and development. Nicola has more than 20 years’ experience in healthcare leadership across the NHS and independent sectors, and was previously Chief Executive of Fortius Clinic.
At London Gynaecology, Nicola is focused on building a sustainable, integrated women’s health business, combining clinical excellence and an exceptional patient experience with greater access. She is passionate about the evolution of women’s healthcare and the opportunity to develop more connected, patient-centred services that better meet women’s needs throughout their lives.
Nina van Schaick – Co-Founder, Peripear
Nina is a midwife with over 12 years of clinical experience, dedicated to improving birth and breastfeeding outcomes. Her career spans hospital settings, community teams, and independent practice, where she combines evidence-based expertise with compassionate care.
A graduate of the Oxford Brookes University Midwifery programme (2012), Nina was awarded the Wellbeing of Women grant in 2010 to fund a placement in Haiti, reflecting her commitment to maternal health. Since 2018, she has focused on independent practice, bringing strong organisational skills, initiative, and natural communication abilities to her leadership role at Peripear.
Paulina Szklarek - Managing Director, Mooncup
Paulina is Managing Director of Mooncup, leading the next stage of growth for a challenger period care brand taking on a category dominated by global giants. With experience scaling businesses across international markets, she combines commercial ambition, operational rigour and a healthy obsession with data to grow Mooncup without losing the bold thinking that made it a challenger in the first place.
Dr Sara Khan - Women's Health & FemTech Advisor, Candesic
Sara is a physician with two decades of experience spanning the NHS, clinical commissioning, and pharmaceutical life sciences, across the UK and Australia. As a former GP, she had a special interest in women’s and sexual health. From 2011 to 2017, she served as Maternity and Gynaecology Commissioner for Herts Valleys CCG, and Vice Chair of Watford & Three Rivers Commissioning Group, leading women’s health service commissioning and transformation serving over 600,000 patients. More recently, Sara has spent the last six years bringing her leadership and medical expertise to the life sciences sector, spanning medical affairs, medical communications and commercial roles across several therapeutic areas.
Sara is a former board member of the Medical Women’s Federation, where she served as Editor of their magazine and events coordinator for their London division. Sara is also co-founder of Dear Daughter, a women’s careers and leadership community, enabling her to share her experience and empower women. She is shortly relocating to Singapore with her family.
14 | Women’s Health and FemTech Conference
laingbuissonevents.com
Sarita Stefani - CEO & Co-Founder, Amilis
Sarita Stefani is co-founder and CEO of Amilis. She spent around eight years in life-sciences data at DRG, Clarivate, IQVIA and Veeva, where she worked on Veeva’s Link oncology platform for top-tier pharma clients. Freezing her own eggs showed her how little realworld data exists on women’s reproductive health. She founded Amilis to capture that data at source, through the clinical system specialists run their practices on, and to build the foundation for pharma and real-world evidence partnerships in women’s health.
Sharon Shier - Executive Director & Chief Customer Officer, WPA
Sharon joined WPA in 1992 and has held numerous roles across the business including, General Manager of the Website, Direct Sales and Underwriting, General Manager of Retail and Head of Product Development. More recently she was Head of Retail and Commercial, before her current role as Chief Customer Officer.
Sophie Burton-Jones - Partner, Mills & Reeve
Sophie Burton-Jones advises organisations across the health, care and technology sectors on complex commercial, technology licensing and data matters. She works closely with innovative healthtech businesses, helping them navigate growth, strategic and commercial challenges. Sophie co-hosts our Talking Digital Health podcast, discussing key topics for those procuring or selling tech and digital products and service in the UK health and care market. She is a passionate advocate for improving outcomes in women’s health and is a leading voice in the firm’s FemHealth Focus initiative, which explores the barriers and opportunities shaping the future of women’s healthcare. Through her work she supports the development and adoption of solutions that improve women’s health outcomes.
Dr Sujitha Selvarajah - Obstetrics and Gynaecology Doctor; Co-Founder, Hesta Health Dr Sujitha Selvarajah is the co-founder of Hesta Health and an Obstetrics & Gynaecology Doctor. Alongside her clinical work, Sujitha has spent over a decade exploring how to improve health at scale. Her journey has taken her into global public health, academia at Oxford and UCL, and international policy and advocacy. Sujitha has been recognised internationally for her work as the first British Women Deliver Young Leader.
Dr Susheel Randhawa - Clinical Lead, Modality Community Gynaecology Service
Dr Susheel Randhawa is a GP with a Special Interest in Women’s Health and Leads the Modality Community Gynaecology Service, one of the UK’s largest integrated community Women’s Health Hubs. She has worked internationally in the UK, Australia and Malaysia, bringing a broad perspective to the delivery of women’s healthcare across different health systems. She leads the development of innovative models of care that bring specialist gynaecology and menopause services closer to home, with a focus on reducing waiting times, improving access and addressing health inequalities. Her work spans digital transformation, AI-enabled pathways, community diagnostics and population health, and she is actively involved in national and international guideline development, research and education. Dr Randhawa is passionate about harnessing innovation and FemTech to improve women’s health outcomes across the life course.
Women’s Health and FemTech Conference | 15
Speakers Suzanne Dickinson - Director Business Development & Engagement, MSI UK Suzanne Dickinson is an accomplished healthcare executive with more than 25 years’ experience across the NHS and independent healthcare sectors. As Director of Business Development & Engagement at MSI Reproductive Choices UK, she leads a national portfolio spanning business development, NHS contracts, advocacy and public affairs, brand, marketing, digital engagement, and external relations.
Recognised for her strategic leadership, stakeholder influence, and commercial acumen, Suzanne works closely with NHS England, Integrated Care Boards, government stakeholders, and executive teams to improve access to healthcare services and strengthen organisational impact. She is particularly passionate about advancing women’s health and reproductive healthcare through innovation, partnership working, and sustainable service development.
Thilo Schneider - Head of Corporate, Mills & Reeve
With over 20 years’ experience as a corporate lawyer, Thilo advises on transactions particularly in the technology, life sciences and health sectors. He advises businesses, their management and investors on the full range of corporate transactional services, including M&A, venture capital and joint venture transactions. He regularly coordinates multi-jurisdictional corporate transactions and due diligence exercises for his clients – he is trusted by clients from Germanspeaking countries to advise on transactions governed by English law and uses his linguistic and cultural understanding to deliver cross-border deals.
Tina Backhouse - Co-Chair, Menopause Mandate
Tina Backhouse is a leading UK voice on women’s health, combining thirty years of commercial leadership in global pharma with a track record of shaping national policy. She built Theramex’s UK & Ireland business from a two-person operation into the company’s largest global affiliate, before going on to establish its first global policy and government affairs function. Alongside her executive career, Tina serves as Vice Chair of Menopause Mandate, sits on the DWP’s Workplace Menopause Working Group, chairs the Women’s Health Action Group, and is an Ambassador for Wellbeing of Women. She has contributed to national policy wins including the NHS Over 40 Health Check and single annual HRT prescription charge, and appears regularly in national media including the BBC, The Times and The Guardian.
Victoria Wain - Investment Director, Phoenix Equity Partners
Victoria Wain is an Investment Director at Phoenix Equity Partners, a leading UK mid-market private equity firm that backs entrepreneurial founders in achieving their growth ambitions. Victoria specialises in healthcare investing, with a particular focus on businesses that support the delivery of high-quality patient care. She is a Non-Executive Director of London Gynaecology, one of the leading women’s health clinic groups in the UK, which Phoenix partnered with in 2024 and is helping to expand the provision of specialist care to more women.
16 | Women’s Health and FemTech Conference
laingbuissonevents.com
Wendy Powell – Founder, MUTU System
Wendy Powell is the founder of MUTU System, a clinical pelvic health and core rehabilitation programme for women across the whole life course, pregnancy through menopause. Built directto-consumer, MUTU has reached more than 150,000 women across over 100 countries, roughly half in the US and half in the UK, and holds one of the largest longitudinal pelvic health outcomes datasets anywhere. Alongside, MUTU holds an NHS contract through the Medway Women’s Health Hub, an independent health economic evaluation commissioned by Health Innovation Kent Surrey Sussex, ORCHA assessment and DTAC alignment, and a listing on Optum Now in the United States. Wendy has spent more than a decade teaching and advocating that ‘common’ is not inevitable.
Get your complimentary digital copy of HealthcareMarkets
Discover the latest HealthcareMarket Issue - your essential guide to the UK’s independent healthcare sector
SCAN TO READ NOW
www.laingbuissonevents.com/LatestHM
Women’s Health and FemTech Conference | 17
In Partnership with
Mills & Reeve is a leading UK law firm, advising organisations at the forefront of health and care, health technology, medtech and life sciences. Our forward-thinking Women’s Health team advises organisations tackling health inequalities, accelerating innovation and improving outcomes for women.
Executive and Drinks Partner
Pharmacierge is the UK’s leading ePrescribing platform and private prescription delivery service. Its free clinician app, mPrescribe®, streamlines prescriber workflows, saving time and delighting patients. Prescriptions are managed at our robot-enabled dispensary in the Harley Street Health District. Trusted, discreet, and efficient, Pharmacierge supports thousands of practitioners across all specialities.
18 | Women’s Health and FemTech Conference
laingbuissonevents.com
Executive Partner
Healistic is the UK’s leading digital e-prescribing platform connecting private prescribers, pharmacies and patients. Free for clinicians - we support menopause, fertility and gynaecology clinics in providing patients fast access to prescription medication, delivered within hours.
Health Search Powered by FROM
COMPLEXITY TO
CLARITY Your premium data tool for independent healthcare sector analysis in the UK
With HealthSearch, you can access exclusive insights into UK independent healthcare providers and groups, combining public and proprietary data, all in one place.
SUBSCRIBE NOW
Make confident decisions by utilising precision filters, including details of specialisms, geography, CQC rating and more, as well as seamless integration with Excel exports.
sales@laingbuisson.com
laingbuisson.com (0)20 7841 0045Conference | 19 Women’s+44 Health and FemTech
Exhibitors
Clear Group is an independent insurance and risk management group providing specialist advice and solutions to businesses across the UK. Through its healthcare and life sciences expertise, Clear supports organisations with tailored insurance, risk, and employee benefits solutions. We have a core focus on protecting Medical Device and MedTech businesses.
IVI Fertility, part of IVI Institute, is built on four decades of scientific leadership and clinical excellence. We unite leading physicians, embryologists and fertility experts to deliver personalised care and advance reproductive medicine. Together, we welcome 35,000 babies annually while advancing the science, technologies and standards that shape fertility care globally.
THEMIS Clinical Defence provides specialist, contractual indemnity tailored to clinical professionals and healthcare institutions. Our clear, non-discretionary cover protects against negligence claims and corporate risks. Combining expert underwriting, real-time claims data, competitive premiums and dedicated Clinical Governance and Claims support, we provide dependable protection, empowering clinicians to focus confidently on patient care.
20 | Women’s Health and FemTech Conference
laingbuissonevents.com
Media Partner
HealthcareMarkets has been a firm feature of the independent healthcare landscape for more than 25 years, covering healthcare services and health cover. The only magazine dedicated to private healthcare, it delivers comprehensive, reliable and independent reporting on the full range of acute and primary healthcare markets operating outside, and in partnership with, the NHS, including acute and mental health hospitals and clinics, dentistry, GP and community services.
Self-pay market sees key demographic shift
Private Healthcare Self-Pay UK Market Report Seventh Edition
The latest edition analyses the UK self-pay healthcare market, showing growth in outpatient, diagnostic, and clinic-based services despite a decline in admitted care. It highlights how self-pay is becoming increasingly popular with under-50s, driven by affordability, flexible payment options, faster access, and changing patient expectations, with providers investing in marketing to engage this influenceable payor group.
What’s in the report: • • • •
Over 70 tables and figures Pricing analysis Provider financial accounts Insights from provider interviews
BUY YOUR COPY NOW
laingbuisson.com +44 (0)20 7841 0045
sales@laingbuisson.com Women’s Health and FemTech Conference | 21
Delegates First Name
Last Name
Company Name/ Organisation
Job Title
Heather
Cook
Ripple Scale Publishing
Managing Director
Tawney
Evans
8foldGovernance Ltd
Account Manager
Glen
Ferris
Healthcare Today
Managing Director
Anthony
Meyerstone
Mayo Clinic Healthcare
Commercial Director
Julie
Jones
BPAS - British Pregnancy Advisory Service
Business Development Manager
Sanwar
Boparai
Department of Health & Social Care
Women’s Health Team Leader
Miran
Bahra
Ashurst Perkins Coie
Associate
Jan
Vickery
Problem Shared
Chief Clinical Growth Officer
Collette
Corrigan
MSI Reproductive Choices
Head of People
Lauren
Miller
Apposite Capital LLP
Investment Director
Ellen
Teesdale
Carnall Farrar
Business Development Manager
Christina
Rashbrook
Carnall Farrar
Business Development, Digital Marketing and commercial intelligence coordinator
Ioana
Ene
IHPN
Senior Policy Advisor
Paula
Bujor
Barclays
Associate Banker
Barry
Cleminson
Clear Insurance Management
Director
Simon
Wyndow
Clear Insurance Management
Director
Dr Anne
King
Square Health
Medical Director
Anisha
Vinayak
Square Health
Proposition Marketing Manager
Anastasiia
Sonina
Healistic
Sales Representative
Tammy
Bate
Imperial College Healthcare NHS TRUST
Executive assistant
Anastasiia
Seliuk
LaingBuisson
Events Coordinator
Timea
Takacs
LaingBuisson
Head of Events
William
Laing
LaingBuisson
CEO
Dan
Robinson
LaingBuisson
Head of Business and Client Relations
Malcolm
Milwood
LaingBuisson
Account Manager
Joe
Perry
LaingBuisson
Account Manager
Maria
Davies
LaingBuisson
Head of Content
Theo
Toulson-Roberts
LaingBuisson
Senior Conference Producer
Naomi
Osunde
LaingBuisson
Events Coordinator
Heidi
Whitman
PPX
Managing Director
Sharon
Shier
WPA
Executive Director, Chief Customer Officer
Sarita
Stefani
Amilis
CEO and Co-founder
Emma
Alho
Private Healthcare Information Network (PHIN)
Product Owner/Business Analyst
22 | Women’s Health and FemTech Conference
laingbuissonevents.com
Women’s Health and FemTech Conference | 23
Delegates First Name
Last Name
Company Name/ Organisation
Job Title
Robyn
Harris
Private Healthcare Information Network (PHIN)
Product Owner/Business Analyst
Ashwani
Sharma
Private Healthcare Information Network (PHIN)
Healthcare Data Analyst
Francesca
Gordon
KPMG
Associate | M&A
Ria
Kutmutia
HSBC UK
Healthcare Sector - Associate Director
Danielle
Hook
HSBC UK
Head of Healthcare
Alice
Sumner
NHS Wales
Doctor
Lola
Mitchell
THEMIS Clinical Defence
Junior Policy Specialist
Alice
Sumner
NHS Wales
Doctor
Kayleigh
Hartigan
SEEN
Founder & CEO
Thilo
Schneider
Mills & Reeve
Head of Corporate
Janet
Lindsay
Wellbeing of Women
CEO
Rebecca
Harker-Smith
Mills & Reeve
Principal Associate
Tania
Richards
Mills & Reeve
Health Policy Lawyer
Mia
Church
Mills & Reeve
Business Development Manager
Lara
Tentori
Alvarez & Marsal
Associate Director - Healthcare & Life Science M&A
Dr Chloe
Curtis
Native Design
Senior Research Strategist
Liz
Jessop
Department of Health
Head of Women's Health
Adrian
Stevensen
Independent Care
Chief Executive Officer
Wendy
Powell
MUTU System
Founder
Andy
Kitchen
Medico Digital
Commercial Director
Adam
Brenton
Compass Associates
Director – Healthcare and Specialist Services
Kevin
Worsley
Compass Associates
Recruitment Consultant – Digital Health
Edward
Ungar
Pharmacierge
CEO & Co-Founder
William
Basing
Pharmacierge
Head of Practice Support
Dana
Lupu
Pharmacierge
Practice Success Lead
Neda
Hormozi
Pharmacierge
Practice Development Associate
Antonia
Adams
Pharmacierge
Practice Support Administrator
Sam
Foakes
Pharmacierge
Practice Liaison Manager
Beena
Khan
One Clinic Leigh
Founder/Clinical Prescribing Pharmacist (Menopause)
Sophie
Burton-Jones
Mills & Reeve
Partner
Lyn
Cruickshank
Wallace Health
Founder
Anni
Feng
Hoare Lea
Associate Director
Victoria
Wain
Phoenix Equity Partners
Investment Director
Liz
Pocock
AXA PPP Healthcare
Head of Health Propositions
24 | Women’s Health and FemTech Conference
laingbuissonevents.com
First Name
Last Name
Company Name/ Organisation
Job Title
Jill
Mason
Mills & Reeve
Partner and Head of Health and Care
Isabel
Teare
Mills & Reeve
Senior Legal Advisor
Dr Sara
Khan
Candesic
Women's Health & FemTech Advisor
James
Flewellen
Kahu SiliconBio
CEO & Co-founder
Bella
Cuthbert
Ernst & Young LLP
Director
Helen
Welch
Hoare Lea
Associate
Deborah
Rowntree
Ashfords LLP
Partner
Rowan
Miller
The London Clinic / UCLH
Consultant Medical Oncologist
Dr Marie
Keka
Tekhi Global for Menopause Health
Chief Executive Officer
Simona
Gemeneanu
Morphosis Capital
Partner
George
Peltecu
Umana Fertility
Founder
Dr. Victor
Stoian
Royal Hospital
Founder
Zara
Thomas
Spire Occupational Health
Director of Strategy & Innovation
Katie
Saxon
BPAS
Chief Strategic Comms Officer
Margot
Northeast
THEMIS Clinical Defence
Principal Associate
Sebastein
Dean
THEMIS Clinical Defence
Senior Associate
Anna
O'Sullivan
CensHERship
Co-founder
Tina
Backhouse
Menopause Mandate
Co-Chair
Professor Regan DBE Dame Lesley
Department of Health and Social Care
Women’s Health Ambassador for England
Suzanne
Dickinson
MSI UK
Director of Business Development & Engagement
Nicola
Aspinall
London Gynaecology
Chief Executive
Abby-Lee
Mulqueen
Mercer Marsh
Strategic Healthcare Programme Lead
Emily
Bridgewater
Mercer Marsh
Client Strategy Leader
Lorraine
Roberts-Rance
Mercer Marsh
UK Workforce Health Leader
Nina
Vegad
Maulin Group
Partnerships and Investigations Director
Jon
Canham
Maulin Group
Chief Customer Officer
Lloyd
Bowden
Healistic
Business Development & Partnership
Rob
Sloan
Healistic
Growth Lead
Zakaria
Khan
Healistic
Head of Business Development
Raj
Kang
Bevan Brittan LLP
Partner
Katy
Jacks
Grant Thornton UK Advisory & Tax LLP
M&A Associate Director
Dr Susheel
Randhawa
Modality Community Gynaecology Service
Clinical Lead
Dr Jane
Benjamin
HCA Primary Care
Women's Health Lead Women’s Health and FemTech Conference | 25
Delegates First Name
Last Name
Company Name/ Organisation
Job Title
Alan
Treharne
West Wales Women’s Wellbeing
Consultant Gynaecologist
Zara
Thomas
Spire Workplace Health
Director of Strategy and Innovation
Richard
Hough
Brabners LLP
Partner
Louisa
Chaves
LEK
Partner
Jacqueline
Thompson
LEK Consulting
Partner
Madilynn
Gardner
Marconi Capital, Ltd.
Research Assistant
Barny
Guthrie
Clinical Partners
CEO
Daniel
Bulkin
Healistic
Founder & CEO
Rosie
Sampson
Sulis Hospital
Women's Physiotherapist
Nathalie
Alpi
PHIN
Digital and Analytics Operations Director
Sylvester
Oppong
Ernst & Young LLP
Partner
Lily
Elsner
Jack Fertility
CEO & Co-Founder
Hugh
Risebrow
LaingBuisson
Author of the Diagnostics Report
Glen
Ferris
Healthcare Today
Managing Director
Marina
Gerner
"The Vagina Business: The Innovative Breakthroughs that Could Change Everything in Women's Health"
Author
Mary
O'Reilly
MOR Advisory; 28X
Founder; Investor & Strategic Advisor
Kate
Lancaster
Royal College of Obstetricians and Gynaecologists
Chief Executive Officer
Katie
Hellewell
KPMG
Assistant Director
Farah
Hashem
KPMG
Corporate Finance - Health & Life Sciences
Gayle
Curry
Mills & Reeve
Partner. Healthcare and Health Tech Commercial Lawyer
Charlotte
Lewis
Mills & Reeve
Principal Associate. Commercial Health and Health Tech lawyer. Women’s Health
Birute
Neville
Circle Health Group
Commercial Development Manager
Jenna
McDonald
London Gynaecology
Growth & Partnerships Lead
Hannah
Partridge
exigere
Associate
Richard
Aris
Healthcode
Director of Strategic Partnerships and External Affairs
Sarah
Colebrook
St John & St Elizabeth Hospital
Chief Nursing Officer
Hannah
O'Connor
St John & St Elizabeth Hospital
Head of Imaging & Cardiology
Vanessa
Sanders
Stanbridge associates ltd
Director
Farah
Hashem
KPMG
Associate
Danielle
Henry
IHPN
Director of Policy
Lin
Li-Williams
Sirkka Health
Founder & CEO
26 | Women’s Health and FemTech Conference
laingbuissonevents.com
First Name
Last Name
Company Name/ Organisation
Job Title
Sacha
Nathan
GAiA Health
Founder & CEO
Cristina
Sabau
The National Heart Clinic
Chief Operating Officer
Krupa
Suthar
Insights that Shine
Research Director
Khushbu
Khilani
IVI Institute
Head of Business Development
Sophie
Kay
IVI Institute
Senior Manager, Marketing Product
Ella
Henry
Newmarket Strategy
Consultant
Laurence
Skillern
Boyd Consultants
Chief Medical Officer
Shaan
Khan
Ovara Health
Chief Operating Officer
Lottie
Bunnage
Newmarket Strategy
Manager
Collette
Corrigan
MSI UK
Head of People
Alanah
Cornelius
MSI UK
Strategic Integration Lead
Paulina
Szklarek
Mooncup
Managing Director
Women’s Health and FemTech Conference | 27
Sustainability in Health & Social Care
Conference
Where ESG meets innovation
Where ESG meets innovation Sustainability is now a strategic imperative in health and social care. The Sustainability in Health and Social Care Conference 2027 unites leaders from hospitals, care homes, community providers, investors and advisors. Across the Healthcare and Social Care streams, delegates will gain practical insights, tools and examples to embed ESG into strategy, reduce emissions, secure green finance, strengthen reputation, and deliver high-quality, future-proof care.
SCAN QR CODE TO LEARN MORE +44(0)20 7841 0045
14 APR 2027 Early Bird Offer Ends:
15 MAR 2027
NatWest Conference Centre, 250 Bishopsgate, London
Venue Partner
sales@laingbuisson.com www.laingbuissonevents.com
28 | Women’s Health and FemTech Conference
laingbuissonevents.com
2026 OPPORTUNITIES PARTNER WITH US Partner with the leading data solutions and market intelligence provider in the UK, specialising in healthcare and social care events. LEARN MORE
laingbuissonevents.com sales@laingbuisson. 44 (0)20 7841 0045 Women’s Health and FemTech Conference | 29
PMI proves to be driving force in private acute market growth
Private Acute Healthcare
UK Market Report Tenth Edition Executive Summary | Market | Politics & Regulation | Payors | NHS Funding | Acute Care Providers | Market Outlook
The latest edition provides in-depth analysis of the £13.79 billion UK private acute healthcare market, which is comprised of independent acute hospitals, NHS private patient units, and independent clinics and privately practising doctors. Drawing on newly available in-year 2025 data and long-term trend analysis, the report highlights key market drivers, including rising insured activity, evolving procedure mix, and regional variations. Essential reading for providers, investors, insurers, and policymakers shaping the future of private acute healthcare in the UK.
£1,835 Single-user Digital PDF PDF License £3,895 Multi-User with Excel Data Workbooks
LaingBuisson is the chosen provider of independent sector healthcare market data to the UK Government’s Office for National Statistics.
ORDER NOW 30 | Women’s Health and FemTech Conference
laingbuisson.com/shop
sales@laingbuisson.com
laingbuissonevents.com
+44 (0)20 7841 0045
28 April 2027
Royal College of Surgeons, London
Where the sector’s defining questions are answered Investing in Healthcare is the must-attend annual conference for stakeholders, investors, operators, and innovators in the UK private healthcare and social care sectors. Drawing key speakers who deliver expert analysis and forecasts, it explores the forces reshaping the market: record institutional capital inflows into care homes and healthcare real estate, private medical insurance growth driven by NHS backlogs, structural bed shortages, consolidation trends, and the workforce and funding pressures that will determine returns. Join the essential conversation on where capital is heading and how the landscape is changing.
REGISTER NOW - EARLY BIRD DISCOUNT ENDS 26 MARCH www.laingbuissonevents.com sales@laingbuisson.com +44 (0)20 7841 0045
Women’s Health and FemTech Conference | 31